These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29511623)

  • 21. Dual gain and loss of cullin 3 function mediates familial hyperkalemic hypertension.
    Cornelius RJ; Zhang C; Erspamer KJ; Agbor LN; Sigmund CD; Singer JD; Yang CL; Ellison DH
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1006-F1018. PubMed ID: 29897280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eleven novel SLC12A1 variants and an exonic mutation cause exon skipping in Bartter syndrome type I.
    Han Y; Zhao X; Wang S; Wang C; Tian D; Lang Y; Bottillo I; Wang X; Shao L
    Endocrine; 2019 Jun; 64(3):708-718. PubMed ID: 30790175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired degradation of medullary WNK4 in the kidneys of KLHL2 knockout mice.
    Kasagi Y; Takahashi D; Aida T; Nishida H; Nomura N; Zeniya M; Mori T; Sasaki E; Ando F; Rai T; Uchida S; Sohara E
    Biochem Biophys Res Commun; 2017 May; 487(2):368-374. PubMed ID: 28414128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease-causing mutations in KLHL3 impair its effect on WNK4 degradation.
    Wu G; Peng JB
    FEBS Lett; 2013 Jun; 587(12):1717-22. PubMed ID: 23665031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired KLHL3-mediated ubiquitination of WNK4 causes human hypertension.
    Wakabayashi M; Mori T; Isobe K; Sohara E; Susa K; Araki Y; Chiga M; Kikuchi E; Nomura N; Mori Y; Matsuo H; Murata T; Nomura S; Asano T; Kawaguchi H; Nonoyama S; Rai T; Sasaki S; Uchida S
    Cell Rep; 2013 Mar; 3(3):858-68. PubMed ID: 23453970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case report of pseudohypoaldosteronism type II with a homozygous KLHL3 variant accompanied by hyperthyroidism.
    Zhang R; Zhang S; Luo Y; Li M; Wen X; Cai X; Han X; Ji L
    BMC Endocr Disord; 2021 May; 21(1):103. PubMed ID: 34022862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
    Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
    Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kelch-like protein 3 in human disease and therapy.
    Lin Y; Li Q; Jin X
    Mol Biol Rep; 2022 Oct; 49(10):9813-9824. PubMed ID: 35585379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights in cullin 3/WNK4 and its relationship to blood pressure regulation and electrolyte homeostasis.
    Andérica-Romero AC; Escobar L; Padilla-Flores T; Pedraza-Chaverri J
    Cell Signal; 2014 Jun; 26(6):1166-72. PubMed ID: 24518042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe Arterial Hypertension from Cullin 3 Mutations Is Caused by Both Renal and Vascular Effects.
    Abdel Khalek W; Rafael C; Loisel-Ferreira I; Kouranti I; Clauser E; Hadchouel J; Jeunemaitre X
    J Am Soc Nephrol; 2019 May; 30(5):811-823. PubMed ID: 30967423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into the diverse mechanisms and effects of variant CUL3-induced familial hyperkalemic hypertension.
    Sharma P; Chatrathi HE
    Cell Commun Signal; 2023 Oct; 21(1):286. PubMed ID: 37845702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel Homozygous KLHL3 Mutation as a Cause of Autosomal Recessive Pseudohypoaldosteronism Type II Diagnosed Late in Life.
    Etges A; Hellmig N; Walenda G; Haddad BG; Machtens JP; Morosan T; Rump LC; Scholl UI
    Nephron; 2022; 146(4):418-428. PubMed ID: 35093948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KLHL2 interacts with and ubiquitinates WNK kinases.
    Takahashi D; Mori T; Wakabayashi M; Mori Y; Susa K; Zeniya M; Sohara E; Rai T; Sasaki S; Uchida S
    Biochem Biophys Res Commun; 2013 Aug; 437(3):457-62. PubMed ID: 23838290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WNK kinases regulate thiazide-sensitive Na-Cl cotransport.
    Yang CL; Angell J; Mitchell R; Ellison DH
    J Clin Invest; 2003 Apr; 111(7):1039-45. PubMed ID: 12671053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms and controversies in mutant Cul3-mediated familial hyperkalemic hypertension.
    Ferdaus MZ; McCormick JA
    Am J Physiol Renal Physiol; 2018 May; 314(5):F915-F920. PubMed ID: 29361671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A familial case of pseudohypoaldosteronism type II (PHA2) with a novel mutation (D564N) in the acidic motif in WNK4.
    Sakoh T; Sekine A; Mori T; Mizuno H; Kawada M; Hiramatsu R; Hasegawa E; Hayami N; Yamanouchi M; Suwabe T; Sawa N; Ubara Y; Fujimaru T; Sohara E; Shinichi U; Hoshino J; Takaichi K
    Mol Genet Genomic Med; 2019 Jun; 7(6):e705. PubMed ID: 31044551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of Renal Electrolyte Transport by WNK and SPAK-OSR1 Kinases.
    Hadchouel J; Ellison DH; Gamba G
    Annu Rev Physiol; 2016; 78():367-89. PubMed ID: 26863326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of type I and type II pseudohypoaldosteronism.
    Furgeson SB; Linas S
    J Am Soc Nephrol; 2010 Nov; 21(11):1842-5. PubMed ID: 20829405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension.
    Cornelius RJ; Maeoka Y; McCormick JA
    Curr Opin Nephrol Hypertens; 2023 Jul; 32(4):335-343. PubMed ID: 37070483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cullin 3 and Blood Pressure Regulation: Insights From Familial Hyperkalemic Hypertension.
    Maeoka Y; Cornelius RJ; McCormick JA
    Hypertension; 2023 May; 80(5):912-923. PubMed ID: 36861484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.